Hugel

Patent cliffs & loss of exclusivity

Hugel is a South Korean active pharmaceutical ingredients manufacturer, based in Gangwon State and listed on the KOSDAQ since 24 December 2015.

Company

Legal NameHugel, Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/hugel-control
Fax Number+82-33-264-3884
Full Address61-20, Sinbuk-ro, Sinbuk-eup, Chuncheon-si, Gangwon-do, Republic of Korea (Postal Code: 24206)
LinkedIn URLhttps://www.linkedin.com/company/hugel/
Pitchbook URLhttps://pitchbook.com/profiles/company/163072-09#overview
Seedtable URLhttps://seedtable.com/companies/hugel

2 upcoming patent cliffs

DrugIngredientTypeCliff
  1. LetyboletibotulinumtoxinA-wlbgBiologicFeb 2036
  2. LetyboletibotulinumtoxinA-wlbgBiologicFeb 2036

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.